No Data
No Data
Citi "Very Bullish" on Gilead's (NASDAQ:GILD) HIV Business
Citi Maintains Gilead Sciences(GILD.US) With Buy Rating, Maintains Target Price $125
Marty Makary and Jay Bhattacharya Clear Senate Hurdles to Lead FDA and NIH
Analysts' Top Healthcare Picks: Corcept Therapeutics (CORT), Gilead Sciences (GILD)
Hospital Stocks Are Ready to Rebound, Deutsche Bank Says
Proposed Medicaid Cuts Would Devastate Local Economies: Report -- Barrons.com
Spread Love N Joy : TSLA $425?
How much did Musk paid Cantor for that silly rating. TSLA Instrinsic Value is about $90.
DAPPER DON : I love moomoo so much
10baggerbamm : when Kennedy starts to execute on his game plan.. companies like general Mills are going to be facing significantly greater expenses. their use of food colors and cereal and in foods in the United States because they're cheaper than using natural colorings will cost them. when high fructose corn syrup is banned and they have to use sugar that's an enormous expense increase. not only to general Mills but it also would hit companies like Coke and Pepsi. this is coming it's happening right now everything is about tariffs once that's put to rest I think you're going to see Kennedy start to bring these issues about health risks and how children need to be protected and we need to ban what's banned in other countries in the United States and I think it's going to happen and these companies are going to be taking a hit to profits as a result